With creative funding schemes picking up steam and nontraditional funders taking an interest in biotech, what can universities and start-ups expect in their right first-round financing structure? At the BIO Technology Transfer Symposium, a panel examined various funding sources as well as the factors that influence investment decisions and the ins and outs of early stage financing deals.
William Tucker, executive director, Innovation Alliances and Services, University of California Office of the President, moderated a discussion with:
Ron Lennox, partner with CHL Medical Partners; and
Dr. Heather M. Snyder, senior associate director with the Alzheimer’s Association.